24小时热门版块排行榜

返回列表

当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖

zhxf

新虫 (小有名气)

应助: 0 (幼儿园)
金币: 306.3
帖子: 84
在线: 49小时
虫号: 657493
注册: 2008-11-18

[交流] 奥巴马总统说：中国药监局歧视美国制药公司的仿制药进入中国市场.你同意吗？已有11人参与

在2013-05-14美国白宫网站上说，中国药监部门（SFDA）对美国制药公司生产的仿制药进口中国市场注册费用为45300RMB，而对中国国内的才1000RMB，由此美国白宫断定：中国药监部门（SFDA）对美国制药公司存在歧视等不公平待遇，因此奥巴马总统现在对此进行全民投票，以形成一法案。众所周知，欧美药厂（特别是那些品牌公司生产的药）在中国市场上一直享受着其“最惠国待遇”，每年在中国市场上赚得钵满盆。可是，他们还是觉得不够。试问，道理何在？让我们大家一起参与投票：反对这法案的通过。
链接网址如下：
https://petitions.whitehouse.gov ... rporations/PQT1npsf
Chinese FDA Discriminates Against the US Pharmaceutical Corporations
The fee for a Chinese pharmaceutical corporation to register "me- too" drugs in China cost RMB1000 ( Approx USD 242). However the same requirement does not apply to american corporations - a fee of RMB 45300 ( Approx USD 7300) is required to register "me-too" drugs in the Chinese market.
The Chinese FDA is discriminating the US pharmaceutical corporations.
The difference of prices is also directly affecting American's ability of exporting "me-too" drugs to Chinese market. The "me-too" drugs market is immensely profitable in China and American corporations are facing heavy and strict regulations by the Chinese FDA. Such policy is affecting the US to create more job opportunities.
Created:May 14, 2013
Issues:Foreign Policy, Regulatory Reform, Trade

回复此楼